InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Capps Kathleen S.. Director active across 1 company, notably Enanta Pharmaceuticals INC. Aggregated, 3 disclosures have been logged. Split: 0 buy · 1 sell. Total volume traded: €4k. Activity tracked since 25 November 2025. The latest transaction was filed on 5 December 2025 (Cession). Regulator: SEC (Form 4). All data is free.
3 of 3 declarations